Lv1
60 积分 2025-11-30 加入
Apolipoprotein E is enriched in dense deposits and is a marker for dense deposit disease in C3 glomerulopathy
29天前
已完结
Oral iptacopan therapy in patients with C3 glomerulopathy: a randomised, double-blind, parallel group, multicentre, placebo-controlled, phase 3 study
29天前
已完结
Current and Emerging Therapies for C3 Glomerulopathy and Primary (Idiopathic) Immune Complex Membranoproliferative Glomerulonephritis
29天前
已完结
Iptacopan Reduces Proteinuria and Stabilizes Kidney Function in C3 Glomerulopathy
29天前
已完结
Clinical Profile and Outcome of C3-Dominant Glomerulonephritis: Retrospective Study
30天前
已完结
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis
1个月前
已完结
Refractory C3 glomerulonephritis unresponsive to bortezomib
1个月前
已关闭
Complement activation drives a compartmentalized innate immune response in C3 glomerulopathy contributing to the disease phenotype
1个月前
已完结
The Difficulties of Treating Complement-3–Mediated Glomerulopathy
1个月前
已完结
Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies
1个月前
已完结
皖公网安备34019202002308
